At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. The innovative products that we provide are helping drive advancements in a multiomic understanding of cellular functions, combining transcriptomics, epigenetics, and proteomics. Multiomics profiling studies enable a more comprehensive understanding of development, cellular response, and disease, fueling the discovery of novel drug targets and biomarkers. The progress our customers have made and what lies ahead inspire us to push the boundaries of what is possible so we can create the next generation of genomics solutions.